《高盛認股證牛熊證》聚焦新股熱潮 看好港交所留意貼價購16361、高槓桿購15951
正股表現:港交所(0388)自上週三起連跌六日,累計跌約6.7%,當中昨日跌約0.1%。今早則見反彈,早段高見371.6元後升幅收窄,中午報369元,升約0.4%。有報導引述消息指,包括中通快遞、再鼎醫藥及寶尊電商的三間中概股將於今日進行上市聆訊,料合共集資達35億美元。此外,華住酒店已向美國證監會遞交在香港第二上市的申請,擬集資9.7億美元。而市場亦持續關注緊接來港上市的IPO。
資金流向:觀察個股認股證資金流向,可見近期資金持續吸納認購證,自本月1號起的7個交易日皆錄得資金流入,合共約7,750萬元。而認沽證則於昨日獲少量資金轉向流入。
產品選擇:投資者如看好,貼價的選擇可留意價外幅度約5%,年期約2個月的低街貨港交購16361。中期價外的選擇則可留意價外幅度約8%,年期約3個月的港交購15951。
港交購16361,行使價388.2元,2020年11月23日到期,實際槓桿9.2倍,貼價、低街貨
港交購15951,行使價400.2元,2020年12月23日到期,實際槓桿7.8倍,中期價外認購證
投資者如看淡,可留意屬行使價318至369元間的認沽證中,槓桿最突出的港交沽17173。
港交沽17173,行使價328.08元,2020年12月30日到期,實際槓桿8.3倍,行使價318至369元間產品中,槓桿最高
高盛其他產品條款:
港交 牛 55397 / 收回價 355.18元 / 行使價 353.18元 / 槓桿比率20.6倍
港交 熊 55520 / 收回價 400元 / 行使價 402元 / 槓桿比率10.3倍
港交 購 25155 / 行使價 439.08元 / 到期日 2021年02月23日 / 實際槓桿6.6倍
註: 以上數據資料來自高盛認股證牛熊證網站~
重要聲明:
以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.